Kevin Martin > Goodwin > Boston, United States > Lawyer Profile
Goodwin Offices
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Kevin Martin
Position
Partner / Co-Chair Appellate & Supreme Court Litigation
Career
Kevin P. Martin is co-chair of the Appellate and Supreme Court Litigation practice at Goodwin, where he has practiced since 2001. Kevin has argued and briefed numerous cases in federal and state appellate courts around the country, and also has extensive experience in both trial matters and internal and government investigations. Prior to joining Goodwin, Kevin clerked for Justice Antonin Scalia on the United States Supreme Court and Judge Laurence Silberman on the U.S. Court of Appeals for the District of Columbia Circuit.
Kevin is a fellow of the American Academy of Appellate Lawyers. The Legal 500 has noted that Kevin is known as an “excellent writer, advocate, and strategist.” He is ranked a “Star” for Appellate Litigation in Massachusetts by Benchmark Litigation, and has been named a “Lawyer of the Year” by Massachusetts Lawyers Weekly for his work before the Massachusetts Supreme Judicial Court (SJC). He has been recognized by the Boston Business Journal as one of its “Power 50,” an annual listing of top executives and “movers and shakers” in the Boston economy. He also serves on Law360’s Massachusetts Editorial Advisory Board. Kevin is the Chair of the board of directors of the New England Legal Foundation, and is a member of Goodwin’s Pro Bono Committee.
Education
JD, Columbia Law School (Kent Scholar) 1999 / BSc, Georgetown University (magna cum laude) 1996
Lawyer Rankings
United States > Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
Lawyers in Goodwin’s practice demonstrate ‘deep and insightful strategic thinking‘, according to clients. A popular choice to represent life sciences and technology clients in appellate work, in line with the wider firm’s signature strengths, the group also had strong recent showings in financial services, class actions and social justice-related appeals. In Washington DC, seasoned group co-chair William Jay is widely lauded for his top-level experience, which includes arguing 17 cases before SCOTUS. Jay is currently representing Novartis in appellate matters related to ongoing European patent litigation between it and Eli Lilly. Also in Washington DC, next-generation partner Brian Burgess is singled out as an ‘outstanding writer and oral advocate‘, while Jaime Santos is noted for her record in ERISA, patent, and constitutional law-related litigation. In Boston, key contacts include department co-chair Kevin Martin, highly active associate Gerard Cedrone, and David Zimmer, who has a focus on IP, administrative law, and consumer finance-related matters.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Industry focus > Education
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Securities litigation: defense
- Finance > Capital markets: debt offerings
- International Trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Real estate > Real estate
- M&A/corporate and commercial > Shareholder activism
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Healthcare > Service providers
- International Trade > Customs, export controls and economic sanctions
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)